BIORA THERAPEUTICS, INC. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Biora Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2019 to Q2 2024.
  • Biora Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $1.57M, a 21.9% decline year-over-year.
  • Biora Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $15.2M, a 74.5% increase year-over-year.
  • Biora Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $16.5M, a 111% increase from 2022.
  • Biora Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $7.8M, a 42.4% decline from 2021.
  • Biora Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $13.6M, a 27.1% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $15.2M $1.57M -$441K -21.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $15.6M $1.54M -$845K -35.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $16.5M $1.55M -$375K -19.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 $16.9M $10.5M +$8.15M +342% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $8.7M $2.01M +$568K +39.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 $8.14M $2.38M +$331K +16.1% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $7.8M $1.92M -$663K -25.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 $8.47M $2.38M -$1.49M -38.4% Jul 1, 2022 Sep 30, 2022 10-Q 2024-05-15
Q2 2022 $9.96M $1.45M -$3.02M -67.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $13M $2.05M -$577K -21.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $13.6M $2.58M +$371K +16.8% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 $13.2M $3.87M +$498K +14.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $12.7M $4.47M +$1.45M +47.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $11.2M $2.63M +$573K +27.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $10.7M $2.21M +$1.31M +146% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-28
Q3 2020 $9.36M $3.37M +$2.74M +435% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $6.61M $3.02M +$2.43M +407% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $4.19M $2.06M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $900K Jan 1, 2020 Jan 31, 2020 10-K 2022-03-28
Q3 2019 $631K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $597K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.